Phagocyte-derived oxidants and plasma antioxidants in haemodialysed patients

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 67, Issue 3, 2007, Pages 343-351

  Soska, V ^a   Ciz, M ^b   Kubala, L ^b   Sobotova, D ^a   Lojek, A ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Chemiluminescence; Hematology; Immunity; Kidney diseases; Markers of oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; BILIRUBIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; IRON; OXIDIZING AGENT; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FEVER; HEMATOLOGY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IMMUNITY; KIDNEY FUNCTION; LABORATORY TEST; LEUKOCYTE; LEUKOCYTOSIS; MALE; NEUTROPHIL; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIOXIDANTS; BILIRUBIN; CHEMILUMINESCENT MEASUREMENTS; FEMALE; FREE RADICALS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; PHAGOCYTES; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; RENAL DIALYSIS; RISK FACTORS; URIC ACID; VITAMIN E;

EID: 34247391938     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510601120428     Document Type: Article

References (30)

1. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000;58:1758-64.
2. Ward RM, McLeish KR. Oxidant stress in hemodialysis patients: What are the determinating factors? Artif Organs 2003;27:230-6.
3. Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, et al. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 2002;58 Suppl 1:S12-19.
4. Kormoczi GF, Rosenkranz AR, Zlabinger GJ. Polymorphonuclear granulocyte stimulation by cellulose-based hemodialysis membranes. Clin Chem Lab Med 1999;37:351-5.
5. Eiselt J, Racek J, Opatrny K Jr. Free radicals and extracorporeal renal replacement therapy. Vnitr Lek 1999;45:319-24.
6. Erdogan C, Unlucerci Y, Turkmen A, Kuru A, Cetin O, Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta 2002;322:157-61.
7. Pavelkova M, Kubala L. Luminol-, isoluminol- and lucigenin-enhanced chemiluminescence of rat blood phagocytes stimulated with different activators. Luminescence 2004;19:37-42.
8. Slavíková H, Lojek A, Hamar J, Dušková M, Kubala L, Vondráček J, et al. Total antioxidant capacity of serum increased in early but not late period after intestinal ischemia in rats. Free Radic Biol Med 1998;25:9-18.
9. Urban T, Hurbain I, Urban M, Clement A, Housset R. Oxidants and antioxidants. Biological effects and therapeutic perspective. Ann Chir 1995;49:427-34.
10. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617-53.
11. Perianayagam MC, Morena M, Jaber BL, Balakrishnan VS. Anti-oxidants reverse uraemia-induced down-regulation of mitochondrial membrane potential and interleukin-10 production. Eur J Clin Invest 2005;35:148-53.
12. Vanholder R, Schepers E, Meert N, Lameire N. What is uremia? Retention versus oxidation. Blood Purif 2006;24:33-8.
13. Glorieux GL, Dhondt AW, Jacobs P, Van Langeraert J, Lameire NH, De Deyn PP, et al. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 2004;65:2184-92.
14. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM. Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Cos Nephro 1993;4:178-86.
15. Vanholder R, Ringoir S, Dhondt A, Hakim R. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991;39:320-7.
16. Descamps-Latscha B, Goldfarb B, Nguyen AT, Landais P, London G, Haeffner-Cavaillon N, et al. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron 1991;59:279-85.
17. Lojek A, Cerný J, Nemec P, Nicovsky J, Soska V, Ciz M, et al. Phagocyte-induced oxidative stress in patients with haemodialysis treatment and organ transplantation. BioFactors 1998;8:165-8.
18. Haag-Weber M, Schollmeyer P, Horl WH. Neutrophil activation during hemodialysis. Adv Exp Med Biol 1989;260:27-37.
19. Horl WH, Steinhauer HB, Schollmeyer P. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. Kidney Int 1985;28:791-6.
20. Cohen MS, Elliott DM, Chplinski T, Pike MM, Niedel JE. A defect in the oxidative metabolism of human polymorphonuclear leukocytes that remain in circulation early in hemodialysis. Blood 1982;60:1283-9.
21. Sela S, Shurtz-Swirski R, Shapiro G, Nasser L, Hamzi M, Shasha SM, et al. Oxidative stress during hemodialysis: effect of heparin. Kidney Int Suppl 2001;78:S159-63.
22. Himmelfarb J, Mcmonagle E, Holbrook D, Toth C. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J Lab Clin Med 1995;126:392-400.
23. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995;41:1135-8.
24. Prakash M, Upadhya S, Prabhu R. Protein thiol oxidation and lipid peroxidation in patients with uraemia. Scand J Clin Lab Invest 2004;64:599-604.
25. Alhamdani MS. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Nephrol Dial Transplant 2005;20:124-8.
26. Alhamdani MS, Al-Najjar AF, Al-Kassir AH. The effect of hemodialysis and dialyzer biocompatibility on erythrocyte glutathione-defense system in chronic hemodialysis patients. Int J Artif Organs 2005;8:576-82.
27. Bergesio F, Monzani G, Ciuti R, Pinzani P, Fiaschi N, Priami F, et al. Total antioxidant capacity: is it an effective method to evaluate the oxidative stress in uraemia? J Biolumin Chemilumin 1998;13:315-19.
28. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46:1723-7.
29. Schettler V, Kuhn W, Kleinoeder T, Armstrong VW, Oellerich M, Muller GA, et al. No acute impact of haemodialysis treatment on free radical scavenging enzyme gene expression in white blood cells. J Intern Med 2003;253:201-17.
30. Dursum E, Ozben T, Süleymanlar G, Dursun B, Yakupoglu G. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002;40:1009-13.